-
Aanjaneya Lifecare Set To Join Hands With Japanese Pharma Major For Breakthrough Anti-Malarial Molecule for Collaborative Research & Co-Marketing
Aanjaneya Lifecare Set To Join Hands With Japanese Pharma Major…
Read more -
Criteria for fixing price of medicines : Srikant Kumar Jena
NPPA fixes or revises prices of controlled drugs / formulations…
Read more -
India Needs to Buck up its Child Health Care
India is showing positive progress in reducing child mortality with…
Read more -
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in Q3, Inches Close To Acquisition
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in…
Read more -
Watch Pfizer Chief Kewal Handa As He Speaks On His Perspectives of The Controversial Draft Pharma Pricing Policy
Watch Pfizer Chief Kewal Handa As He Speaks On His…
Read more -
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners In “Neutraceutical Segments” & “Company Of The Year Award” Respectively at 4th Annual Pharmaceutical Leadership Awards 2011
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners In…
Read more -
Price Control of Medicines are detrimental for India’s Healthcare Growth Story & Drives – Kewal Handa, MD, Pfizer & Wyeth India.
Price Control of Medicines are detrimental for India’s Healthcare Growth…
Read more -
Health insurance industry needs a Make-Over!!!
Health insurance industry needs such a pro-active policy change, which…
Read more -
PC allocated Rs 21,229 crore in the 2013-2014 budget, a 24% increase over the allocation to NRHM in 2012-2013 budget.
Budget 2013: Inflation to offsets 22% rise in healthcare allocation…
Read more -
Pharma & Healthcare Loses Focus in PC’S Budget!!!
Budget could have delivered more for healthcare, pharma sectors Healthcare…
Read more